Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-08-16
2011-08-16
Chu, Yong (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S384000, C548S132000, C548S263200
Reexamination Certificate
active
07998988
ABSTRACT:
The invention relates to biphenyl compounds of formula (I):wherein U, V and W together form a group of the formula *—CH═CH—CH<, *—CH2—CH2—CH< or *—CH2—CH2—N<, in which * means the point of linkage to the phenyl ring; A is O or CH2; and D, E, X, Y, Z, R1, R2, o, n, and p are as defined in the specification. The invention also relates to pharmaceutical compositions of the compound of the compounds. The compounds and pharmaceutical compositions of the invention can be used in the treatment or prevention of cardiovascular disorders.
REFERENCES:
patent: 5041638 (1991-08-01), Rosentreter et al.
patent: 5159097 (1992-10-01), Rosentreter et al.
patent: 5221760 (1993-06-01), Rosentreter et al.
patent: 6166027 (2000-12-01), Straub et al.
patent: 6180656 (2001-01-01), Furstner et al.
patent: 6387940 (2002-05-01), Straub et al.
patent: 6410740 (2002-06-01), Straub et al.
patent: 6414009 (2002-07-01), Straub et al.
patent: 6451805 (2002-09-01), Straub et al.
patent: 6462068 (2002-10-01), Straub et al.
patent: 6864287 (2005-03-01), Alonso-Alija et al.
patent: 7087644 (2006-08-01), Alonso-Alija et al.
patent: 7517896 (2009-04-01), Alonso-Alija et al.
patent: 2004/0082798 (2004-04-01), Alonso-Alija et al.
patent: 2004/0176446 (2004-09-01), Alonso-Alija et al.
patent: 2006/0094769 (2006-05-01), Alonso-Alija et al.
patent: 2007/0179139 (2007-08-01), Alonso-Alija et al.
patent: 2008/0058314 (2008-03-01), Alonso-Alija et al.
patent: 19943635 (2001-03-01), None
patent: 19943636 (2001-03-01), None
patent: 19943639 (2001-03-01), None
patent: 19943634 (2001-04-01), None
patent: 0341551 (1989-11-01), None
patent: WO-98/16223 (1998-04-01), None
patent: WO-98/16507 (1998-04-01), None
patent: WO-98/23619 (1998-06-01), None
patent: WO-01/19355 (2001-03-01), None
patent: WO-01/19776 (2001-03-01), None
patent: WO-01/19778 (2001-03-01), None
patent: WO-01/19780 (2001-03-01), None
patent: WO-02/070462 (2002-09-01), None
patent: WO-02/070510 (2002-09-01), None
Vippagunta et al, “Crystalline Solids”, Advanced Drug Delivery Reviews, vol. 48, pp. 3-26 (2001).
Gavezzotti, “Are Crystal Structures Predictable?”, Accounts of Chemical Research, vol. 27, pp. 309-314 (1994).
Souillac, et al., Characterization of Delivery Systems, Differential Scanning Calorimetry, pp. 217-218 (in Encyclopedia of Controlled Drug Delivery, 1999, John Wiley & Sons, pp. 212-227).
Sausville et al.(Cancer Res. 2006; 66 (7): 3351-3354).
Wermuth et al., “Molecular Variations Based on Isosteric Replacements”, Practice of Medicinal Chemistry, 1996; pp. 203-237.
FN Ko et al.: “YC-1, A Novel Activator of Platelet Guanylate Cyclase,” Blood, 84, 1994, pp. 4226-4233.
A. Mulsch et al.: “Effect of YC-1, an NO-independent, Superoxide-Sensitive Stimulator of Soluble Guanylyl Cyclase, on Smooth Muscle Responsiveness to Nitrovasodilators,” British Journal of Pharmacology, 120, 1997, pp. 681-689.
D. B. Glass et al.: “Stimulation of Human Platelet Guanylate Cyclase by Fatty Acids,” The Journal of Biological Chemistry, vol. 252, No. 4, Feb. 25, 1977, pp. 1279-1285.
D. J. Pettibone et al.: “A Structurally Novel Stimulator of Guanylate Cyclase with Long-Lasting Hypotensive Activity in the Dog,” European Journal of Pharmacology, 116, 1985, pp. 307-312.
S-M Yu et al.: “Vasorelaxant Effect of Isoliquiritigenin, a Novel Soluble Guanylate Cyclase Activator, in Rat Aorta,” British Journal of Pharmacology, 114, 1995, pp. 1587-1594.
R. Gerzer et al.: “Soluble Guanylate Cyclase Purified from Bovine Lung Contains Heme and Copper,” FEBS Letters, vol. 132, No. 1, Sep. 1981, pp. 71-74.
M. Hoenicka et al.: “Purified Soluble Guanylyl Cyclase Expressed in a Baculovirus/Sf9 System: Stimulation by YC-1, Nitric Oxide, and Carbon Monoxide,” J. Mol. Med, 77, 1999, pp. 14-23.
L. J. Ignarro: “Regulation of Cytosolic Guanylyl Cyclase by Porphyrins and Metalloporphyrins,” Advances in Pharmacology, vol. 26, 1994, pp. 35-65.
C. G. Wermuth: “Designing Prodrugs and Bioprecursors II: Bioprecursor Prodrugs,” The Practice of Medicinal Chemistry, No. 32, 1996, pp. 697-715.
Bartel Stephan
Hahn Michael
Moradi Wahed Ahmed
Münter Klaus
Rölle Thomas
Bayer Schering Pharma Aktiengellschaft
Chu Yong
King Karen B.
Rodriguez-Garcia Valerie
LandOfFree
Biphenyl compounds useful in the treatment or prevention of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biphenyl compounds useful in the treatment or prevention of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biphenyl compounds useful in the treatment or prevention of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2641659